How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

Affiliations

• ¹ University of Hertfordshire, Hatfield, UK; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK; University of Cambridge School of Clinical Medicine, Cambridge, UK. Electronic address: naomi.fineberg@nhs.net.
• ² Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada.
• ³ SW London and St George's NHS Trust and St George's, University of London, UK.
• ⁴ Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
• ⁵ SA MRC Unit on Risk & Resilience in Mental Disorders, Dept of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
• ⁶ Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, USA.
• ⁷ Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Switzerland; Zurich Center for Integrative Human Physiology, University of Zurich, Switzerland.
• ⁸ Istituto di Neuroscienze, University of Florence, Italy; Albert Einstein College of Medicine, New York, USA.
• ⁹ University of Hertfordshire, Hatfield, UK; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK; Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy.
• ¹⁰ The Post Trauma Center, Chaim Sheba Medical Center, Israel; Tel Aviv University, Israel.
• ¹¹ Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
• ¹² Department of Psychiatry, Bellvitge University Hospital-IDIBELL, University of Barcelona, Cibersam, Barcelona, Spain.
• ¹³ Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS-3Bs PT Government Associate Laboratory, Braga/Guimarães, Portugal; Clinical Academic Center - Braga, Hospital de Braga, Braga, Portugal.
• ¹⁴ University of Hertfordshire, Hatfield, UK; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK.
• ¹⁵ Turner Institute for Brain and Mental Health, Monash University, Victoria, Australia; D'Or Institute for Research and Education and Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
• ¹⁶ Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, USA.
• ¹⁷ Brain Center Firenze, Florence, Italy.
• ¹⁸ SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, University of Stellenbosch, South Africa.
• ¹⁹ Department of Psychiatry, Amsterdam UMC location VUMC, Amsterdam, the Netherlands.
• ²⁰ Orchard, 66 Devonshire Road, Cambridge CB1 2BL, UK.
• ²¹ The Post Trauma Center, Chaim Sheba Medical Center, Israel.
• ²² Independent researcher.
• ²³ Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico; Clinical Research, Carracci Medical Group, Mexico City, Mexico.
• ²⁴ University of Milan, Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy; "Aldo Ravelli" Center for Neurotechnology and Brain Therapeutic, University of Milan, Milan, Italy.